American Express Company (AXP)
Latest news, insights and market data
Market Data
AI Insights
American Express has been upgraded to Neutral by Redburn after a significant price drop since January, suggesting a more balanced valuation. This shift comes as the company continues to show solid revenue growth, which could help restore investor confidence. Watch for how this upgrade impacts AXP's market perception moving forward.
Latest News
| Title | Published |
|---|---|
American Express (AXP) Remains a Key Holding for Mario Gabelli American Express (AXP) Remains a Key Holding for Mario Gabelli | about 9 hours ago |
American Express (AXP) Remains a Key Holding for Mario Gabelli American Express Company (NYSE:AXP) is one of the best stocks to buy according to billionaire Mario Gabelli. American Express Company (NYSE:AXP) is the sixth-largest 13F holding for GAMCO Investors, with $156 million invested, giving it a 1.5% weight in the portfolio. GAMCO holds 422,221 shares as of Q4 2025, down around 6% from Q3 2025. […] | about 9 hours ago |
Visa Packs Its Bags for APAC Travel Boom: A Virtual Card Play Visa Packs Its Bags for APAC Travel Boom: A Virtual Card Play | about 17 hours ago |
Visa Packs Its Bags for APAC Travel Boom: A Virtual Card Play V teams with Trip.com to launch a global virtual travel card program that streamlines B2B payments and taps into the Asia Pacific travel rebound. | about 17 hours ago |
NanoViricides Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026 - Announces Manufacture of Phase II Clinical Product NV-387 Oral Gummies is Complete NanoViricides Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026 - Announces Manufacture of Phase II Clinical Product NV-387 Oral Gummies is Complete | about 18 hours ago |
NanoViricides Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026 - Announces Manufacture of Phase II Clinical Product NV-387 Oral Gummies is Complete SHELTON, CT / ACCESS Newswire / March 11, 2026 / NanoViricides, Inc. (AMEX:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, is pleased to announce that it will be ... | about 18 hours ago |
These 4 ETFs Generate $6,000 a Year in Monthly Income for Retirement Investors These 4 ETFs Generate $6,000 a Year in Monthly Income for Retirement Investors | about 19 hours ago |
American Express (AXP) Remains a Key Holding for Mario Gabelli
American Express (AXP) Remains a Key Holding for Mario Gabelli
American Express (AXP) Remains a Key Holding for Mario Gabelli
American Express Company (NYSE:AXP) is one of the best stocks to buy according to billionaire Mario Gabelli. American Express Company (NYSE:AXP) is the sixth-largest 13F holding for GAMCO Investors, with $156 million invested, giving it a 1.5% weight in the portfolio. GAMCO holds 422,221 shares as of Q4 2025, down around 6% from Q3 2025. […]
Visa Packs Its Bags for APAC Travel Boom: A Virtual Card Play
Visa Packs Its Bags for APAC Travel Boom: A Virtual Card Play
Visa Packs Its Bags for APAC Travel Boom: A Virtual Card Play
V teams with Trip.com to launch a global virtual travel card program that streamlines B2B payments and taps into the Asia Pacific travel rebound.
NanoViricides Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026 - Announces Manufacture of Phase II Clinical Product NV-387 Oral Gummies is Complete
NanoViricides Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026 - Announces Manufacture of Phase II Clinical Product NV-387 Oral Gummies is Complete
NanoViricides Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026 - Announces Manufacture of Phase II Clinical Product NV-387 Oral Gummies is Complete
SHELTON, CT / ACCESS Newswire / March 11, 2026 / NanoViricides, Inc. (AMEX:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, is pleased to announce that it will be ...
These 4 ETFs Generate $6,000 a Year in Monthly Income for Retirement Investors
These 4 ETFs Generate $6,000 a Year in Monthly Income for Retirement Investors